In conclusion, OLFM2 in the liver seems to play a relevant role in NAFLD progression, while OLFM4 in the jejunum could be involved in gut dysbiosis-related inflammatory events. Here, OLFM4 is linked to metabolic dysfunction-associated steatotic liver disease.